GO:0032998 Fc-epsilon receptor I complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032998 (Fc-epsilon receptor I complex) is a cell-surface protein complex that functions primarily as the high-affinity activating receptor for immunoglobulin E (IgE).
• The complex is composed of an Fc-epsilon RI alpha chain and an Fc-epsilon RI gamma chain dimer, with or without an Fc-epsilon RI beta chain and additional signaling components.
• Fc-epsilon receptor I complex binds IgE with 1:1 stoichiometry and high affinity, a property central to allergic sensitization.
• Crosslinking of IgE-bound Fc-epsilon receptor I complex triggers Lyn-dependent phosphorylation events and mast cell activation, which can be negatively regulated by Fc gamma receptor IIB.
• The complex is expressed on mast cells, basophils, and other cell types, and contributes to antigen-evoked pruritus in ocular allergy models.
• Chimeric Fc-epsilon receptor I has been used experimentally to redirect cytotoxic T lymphocytes to tumors, showing its potential in engineered cell therapies.
Description
The Fc-epsilon receptor I complex (GO:0032998) is the high-affinity cell-surface receptor for immunoglobulin E (IgE) and the principal trigger of immediate hypersensitivity reactions. It is a multi-subunit protein complex that couples allergen recognition to intracellular signaling cascades in mast cells, basophils, and other effector cells. Because of its central role in allergic disease, the complex is a major target for mechanistic studies and therapeutic development. The complex is defined in QuickGO as a protein complex composed of an Fc-epsilon RI alpha chain and an Fc-epsilon RI gamma chain dimer with or without an Fc-epsilon RI beta chain and additional signaling components, functioning primarily as an activating receptor for IgE. Researchers study GO:0032998 to understand how IgE-dependent activation is initiated, how signaling is propagated and terminated, and how the complex can be manipulated in engineered immune cells. The complex also appears in non-classical contexts, such as neuronal Fc-epsilon receptor I contributing to antigen-evoked pruritus in a murine model of ocular allergy. This article summarizes the composition, assembly, molecular mechanism, disease relevance, and research methods for GO:0032998, with all factual statements supported by verified PubMed citations.
Fc-epsilon receptor I complex At A Glance
| GO ID | GO:0032998 |
|---|---|
| GO term | Fc-epsilon receptor I complex |
| Ontology | cellular_component |
| Synonym | FceRI complex; IgE receptor complex; immunoglobulin E receptor complex |
| Major function | Activating receptor for IgE; triggers mast cell and basophil signaling upon allergen crosslinking |
| Subunit composition | Fc-epsilon RI alpha chain, Fc-epsilon RI gamma chain dimer, optional Fc-epsilon RI beta chain and additional signaling components |
| Ligand | Immunoglobulin E (IgE) |
| Stoichiometry | 1:1 high-affinity receptor-IgE complex |
| Associated signaling | Lyn-dependent phosphorylation and negative regulation by Fc gamma receptor IIB |
What Is GO:0032998?
GO:0032998 (Fc-epsilon receptor I complex) is a cellular component ontology term describing a protein complex that includes an Fc-epsilon RI alpha chain and an Fc-epsilon RI gamma chain dimer, optionally with an Fc-epsilon RI beta chain and additional signaling components. The complex functions primarily as an activating receptor for IgE. Synonyms include FceRI complex, IgE receptor complex, and immunoglobulin E receptor complex.
Why Is Fc-epsilon receptor I complex Important in Cell Biology?
The Fc-epsilon receptor I complex is important because it is the primary receptor that initiates IgE-mediated allergic responses, including mast cell degranulation and release of inflammatory mediators. Its high-affinity 1:1 interaction with IgE makes it a key determinant of allergic sensitization. Understanding its regulation, including Lyn-dependent phosphorylation and negative feedback via Fc gamma receptor IIB, is essential for developing therapies that modulate allergic inflammation. The complex also has broader biological roles, such as contributing to antigen-evoked pruritus in ocular allergy models and serving as a component of engineered receptors for redirecting T cells to tumors.
• Central to IgE-mediated allergic disease and immediate hypersensitivity.
• High-affinity 1:1 binding to IgE enables sensitive allergen detection.
• Triggers Lyn-dependent signaling and mast cell activation.
• Negatively regulated by Fc gamma receptor IIB, providing a checkpoint for activation.
• Expressed in mast cells, basophils, and other effector cells.
• Contributes to antigen-evoked pruritus in ocular allergy models.
• Chimeric Fc-epsilon receptor I can redirect cytotoxic T lymphocytes to tumors.
• Kinetic proofreading models help explain its signaling fidelity.
• A target for anti-allergic therapeutic strategies.
• Relevant to engineered immune cell therapies.
Fc-epsilon receptor I complex: Biological Process, Cellular Component, and Molecular Function
IgE Binding and Sensitization
In simple terms: The receptor grabs IgE antibodies and holds them on the cell surface, arming the cell for an allergic response.
The Fc-epsilon receptor I complex binds IgE with high affinity and 1:1 stoichiometry, a property that is fundamental to allergic sensitization. This interaction allows the cell to display IgE on its surface, ready to recognize specific allergens. The binding is the first step in the activation cascade that leads to allergic reactions.
Allergen Crosslinking and Receptor Activation
In simple terms: When an allergen binds to the IgE on the receptor, it pulls multiple receptors together, switching on the cell.
Upon allergen binding, IgE molecules on adjacent Fc-epsilon receptor I complexes are crosslinked, leading to receptor aggregation and activation. This crosslinking initiates intracellular signaling events that are critical for mast cell and basophil activation. The process is a key trigger of immediate hypersensitivity.
Lyn-Dependent Phosphorylation and Negative Regulation
In simple terms: The receptor sends signals inside the cell, but there is also a brake that can stop the signal.
Activated Fc-epsilon receptor I complex associates with Lyn kinase, which phosphorylates downstream targets, including Fc gamma receptor IIB, during negative regulation of mast cell activation. This Lyn-dependent phosphorylation is part of a feedback mechanism that limits the intensity of the allergic response. The balance between activating and inhibitory signals determines the cellular outcome.
Kinetic Proofreading in Signaling
In simple terms: The receptor uses a timing mechanism to make sure it only responds to the right signals.
Kinetic proofreading models describe how the Fc-epsilon receptor I complex can discriminate between different ligands based on the duration of receptor-ligand interactions. This mechanism helps ensure that signaling is triggered only by appropriate stimuli, contributing to the fidelity of the allergic response. The model is widely used to understand receptor signaling dynamics.
Neuronal Expression and Pruritus
In simple terms: The receptor is not only in immune cells; it can also be found on neurons and cause itching.
Neuronal Fc-epsilon receptor I contributes to antigen-evoked pruritus in a murine model of ocular allergy. This finding expands the known roles of the complex beyond classical immune cells. It suggests that the receptor may be involved in sensory neural pathways related to allergy.
Key Genes Involved in GO:0032998 Fc-epsilon receptor I complex
The following genes and proteins are key components or regulators of the Fc-epsilon receptor I complex and its signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FCER1A | Encodes the alpha chain of the Fc-epsilon receptor I complex | Required for IgE binding and receptor assembly |
| FCER1G | Encodes the gamma chain, which forms a dimer in the complex | Essential for signaling and receptor surface expression |
| FCER1B | Encodes the beta chain, an optional component of the complex | Modulates receptor signaling and amplification |
| MS4A2 | Encodes the beta chain of the high-affinity IgE receptor | Amplifies signaling in mast cells |
| LYN | Kinase that phosphorylates downstream targets upon receptor activation | Key mediator of activating and inhibitory signals |
| FCGR2B | Inhibitory receptor phosphorylated by Lyn during negative regulation | Provides a brake on mast cell activation |
| IGHE | Encodes the epsilon heavy chain of IgE | Ligand for the Fc-epsilon receptor I complex |
| IGE | Immunoglobulin E antibody | Binds the receptor with high affinity |
| SYK | Downstream kinase in Fc-epsilon receptor I signaling | Propagates activating signals |
| BTK | Tyrosine kinase involved in mast cell signaling | Potential therapeutic target in allergy |
| PLCG1 | Phospholipase C gamma 1, downstream of receptor activation | Mediates calcium flux and degranulation |
| PIK3CD | Phosphoinositide 3-kinase catalytic subunit delta | Contributes to signaling and cell activation |
| CD23 | Low-affinity IgE receptor, interacts with CD23-mediated signals | Cross-talk with Fc-epsilon receptor I pathways |
| IL4 | Cytokine that promotes IgE class switching | Regulates IgE production and receptor sensitization |
| IL13 | Cytokine involved in allergic inflammation | Modulates IgE responses |
| STAT6 | Transcription factor downstream of IL-4/IL-13 signaling | Regulates genes involved in IgE production |
| GATA2 | Transcription factor important for mast cell development | Controls expression of Fc-epsilon receptor I components |
| SPI1 | Transcription factor PU.1, regulates mast cell gene expression | Influences receptor expression |
How Is Fc-epsilon receptor I complex Regulated?
The Fc-epsilon receptor I complex is regulated at multiple levels. Lyn-dependent phosphorylation of Fc gamma receptor IIB provides a negative feedback mechanism that dampens mast cell activation. Kinetic proofreading ensures that only sustained receptor-ligand interactions lead to full signaling, preventing inappropriate activation. Additionally, the presence or absence of the beta chain (encoded by MS4A2/FCER1B) modulates the signaling strength of the complex. Cytokines such as IL-4 and IL-13 can influence IgE production and receptor sensitization, indirectly affecting complex activity.
Fc-epsilon receptor I complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FCER1A | Allergic asthma and rhinitis | Knockout mouse or human mast cell line with FCER1A deletion |
| FCER1G | Mast cell activation disorders | Point mutation to disrupt gamma chain signaling |
| MS4A2 | Atopic dermatitis | Overexpression of beta chain in mast cells |
| LYN | Negative regulation of mast cell activation | Knockout of LYN to study loss of inhibitory phosphorylation |
| FCGR2B | Autoimmune and allergic inflammation | Knock-in of phosphorylation-deficient FCGR2B |
Allergic Diseases
The Fc-epsilon receptor I complex is central to the pathogenesis of allergic diseases, including asthma, allergic rhinitis, and atopic dermatitis, because it mediates IgE-dependent mast cell and basophil activation. Allergen-specific IgE binds to the complex, leading to crosslinking and release of inflammatory mediators. Therapeutic strategies often target this receptor or its downstream signaling to reduce allergic symptoms.
Ocular Allergy and Pruritus
Neuronal Fc-epsilon receptor I contributes to antigen-evoked pruritus in a murine model of ocular allergy, indicating a role beyond classical immune cells. This suggests that the complex may be involved in itch sensation during ocular allergic reactions. Targeting neuronal Fc-epsilon receptor I could be a novel approach for treating allergic itch.
Cancer Immunotherapy
Chimeric human Fc-epsilon receptor I has been used to redirect cytotoxic T lymphocytes to tumors, demonstrating the potential of engineering this receptor for cancer therapy. This approach exploits the high-affinity binding properties of the receptor to recognize tumor-associated antigens. It represents an innovative application of the complex outside of allergy.
Cardiac Remodeling
Spleen-heart cross-talk through CD23-mediated signals, which intersect with Fc-epsilon receptor I pathways, can promote cardiac remodeling. This highlights a broader role for IgE-related signaling in cardiovascular biology. Further research is needed to fully understand the contribution of the Fc-epsilon receptor I complex in this context.
From Fc-epsilon receptor I complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FCER1A loss abolish IgE binding? | FCER1A knockout mast cell line |
| How does a point mutation in FCER1G affect signaling? | Point-mutation knock-in of FCER1G |
| Can a tagged Fc-epsilon receptor I complex be tracked? | Knock-in of fluorescent tag on FCER1A |
| What is the effect of beta chain overexpression? | Overexpression of MS4A2 in basophils |
| Does Lyn-mediated negative regulation require FCGR2B? | FCGR2B knockout or point mutant |
| Can chimeric Fc-epsilon receptor I redirect T cells? | Knock-in of chimeric receptor in primary T cells |
How to Study the Fc-epsilon receptor I complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface expression of receptor subunits | Mast cell and basophil phenotyping |
| IgE binding assay | Affinity and stoichiometry of IgE-receptor interaction | Characterizing receptor-ligand binding |
| Phosphoproteomics | Lyn-dependent phosphorylation events | Mapping signaling pathways |
| Western blot | Specific protein phosphorylation and expression | Validating signaling changes |
| Surface plasmon resonance | Kinetics of IgE binding | Determining association/dissociation rates |
| CRISPR knockout | Loss-of-function of receptor subunits | Testing necessity of genes |
| CRISPR knock-in | Tagged or mutant receptor expression | Tracking and functional studies |
| Library screening | Identification of modifiers of receptor function | High-throughput gene discovery |
Flow Cytometry and Ligand Binding Assays
Flow cytometry can measure surface expression of Fc-epsilon receptor I complex subunits on mast cells and basophils. Ligand binding assays using fluorescently labeled IgE can determine affinity and stoichiometry. These methods are essential for characterizing receptor assembly and function.
Phosphoproteomics and Signaling Analysis
Phosphoproteomics can identify Lyn-dependent phosphorylation events downstream of Fc-epsilon receptor I activation, including phosphorylation of Fc gamma receptor IIB. Western blotting and immunoprecipitation are used to confirm specific phosphorylation sites. These techniques help map the signaling network.
Kinetic Measurements and Modeling
Surface plasmon resonance and stopped-flow kinetics can measure the binding and dissociation rates of IgE to the Fc-epsilon receptor I complex. Kinetic proofreading models are then applied to interpret signaling fidelity. These approaches provide quantitative insights into receptor function.
Genetic Engineering and CRISPR Screens
CRISPR knockout, knock-in, and point mutation strategies can be used to dissect the role of individual subunits and signaling motifs in the Fc-epsilon receptor I complex. Library screening can identify modifiers of receptor expression or signaling. These methods enable causal testing of candidate genes.
How CRISPR Can Be Used to Study GO:0032998 Fc-epsilon receptor I complex
Knockout
CRISPR knockout of FCER1A, FCER1G, or MS4A2 can abolish Fc-epsilon receptor I complex expression and function, allowing researchers to test the requirement of each subunit for IgE binding and signaling. Knockout of LYN or FCGR2B can reveal their roles in negative regulation. These models are valuable for dissecting the contribution of individual components to allergic responses.
Point Mutation
Point mutations can be introduced into signaling motifs, such as the immunoreceptor tyrosine-based activation motifs (ITAMs) in FCER1G, to study their role in receptor activation. Mutating phosphorylation sites in FCGR2B can disrupt negative regulation, leading to enhanced mast cell activation. These precise edits help define structure-function relationships.
Knock-in
Knock-in of fluorescent or epitope tags on FCER1A or FCER1G enables real-time tracking of receptor trafficking and assembly. Knock-in of chimeric receptors, such as a chimeric human Fc-epsilon receptor I, can redirect T cells to tumors. These models are powerful for both basic and translational research.
Overexpression
Overexpression of the beta chain (MS4A2) or other signaling components can amplify Fc-epsilon receptor I signaling and is useful for studying gain-of-function phenotypes. Overexpression of IgE or cytokines like IL-4 can enhance receptor sensitization. These models help identify thresholds and saturation effects in the pathway.
How EDITGENE Supports Fc-epsilon receptor I complex Research
Researchers studying Fc-epsilon receptor I complex-related genes often need to determine whether a candidate gene is causally involved in receptor assembly, signaling, or allergic disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for Fc-epsilon receptor I complex research.
Frequently Asked Questions About Fc-epsilon receptor I complex
What is the Fc-epsilon receptor I complex?
The Fc-epsilon receptor I complex (GO:0032998) is a cell-surface protein complex that functions as the high-affinity activating receptor for IgE, composed of an alpha chain, a gamma chain dimer, and optionally a beta chain and other signaling components.
What genes are involved in the Fc-epsilon receptor I complex?
Key genes include FCER1A (alpha chain), FCER1G (gamma chain), MS4A2/FCER1B (beta chain), LYN, FCGR2B, and IGHE (IgE).
What is the function of GO:0032998?
GO:0032998 functions primarily as an activating receptor for IgE, triggering mast cell and basophil activation upon allergen crosslinking.
How does the Fc-epsilon receptor I complex bind IgE?
It binds IgE with high affinity and 1:1 stoichiometry, allowing the cell to display IgE on its surface for allergen recognition.
What diseases are associated with the Fc-epsilon receptor I complex?
It is associated with allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis, and has roles in ocular allergy and cancer immunotherapy.
How is the Fc-epsilon receptor I complex regulated?
It is regulated by Lyn-dependent phosphorylation and negative feedback via Fc gamma receptor IIB, as well as kinetic proofreading mechanisms.
What is the role of Lyn in Fc-epsilon receptor I signaling?
Lyn phosphorylates downstream targets, including Fc gamma receptor IIB, during negative regulation of mast cell activation.
Can the Fc-epsilon receptor I complex be used in cancer therapy?
Yes, chimeric human Fc-epsilon receptor I has been used to redirect cytotoxic T lymphocytes to tumors.
What model systems are used to study the Fc-epsilon receptor I complex?
Common models include knockout, point mutation, knock-in, and overexpression cell lines, as well as murine models of allergy.
What research methods are used for GO:0032998?
Methods include flow cytometry, IgE binding assays, phosphoproteomics, kinetic measurements, and CRISPR screens.
Conclusion
The Fc-epsilon receptor I complex (GO:0032998) is a critical mediator of IgE-dependent allergic responses and a key target for therapeutic intervention. Its multi-subunit composition, high-affinity IgE binding, and complex regulation by kinases and inhibitory receptors make it a rich subject for mechanistic and translational research. Advances in CRISPR-based models and screening technologies continue to illuminate its roles in allergy, pruritus, and even cancer immunotherapy. Understanding this complex at molecular resolution will aid in the development of novel treatments for allergic and immune-related diseases.
References
- 1. Shamji MH et al.. 2021. The role of allergen-specific IgE, IgG and IgA in allergic disease.. Allergy 76(12):3627-3641 PMID: 33999439
- 2. Feng Y et al.. 2025. Spleen-Heart Cross-Talk Through CD23-Mediated Signal Promotes Cardiac Remodeling.. Circ Res 137(1):83-102 PMID: 40391441
- 3. Liu F et al.. 2017. Neuronal Fc-epsilon receptor I contributes to antigen-evoked pruritus in a murine model of ocular allergy.. Brain Behav Immun 61:165-175 PMID: 27865948
- 4. Goldstein B et al.. 2008. Kinetic proofreading model.. Adv Exp Med Biol 640:82-94 PMID: 19065786
- 5. Kershaw MH et al.. 1996. The use of chimeric human Fc(epsilon) receptor I to redirect cytotoxic T lymphocytes to tumors.. J Leukoc Biol 60(6):721-8 PMID: 8975874
- 6. Vercelli D et al.. 1989. The IgE system.. Ann Allergy 63(1):4-11 PMID: 2525888
- 7. Keown MB et al.. 1997. Basis of the 1:1 stoichiometry of the high affinity receptor Fc epsilon RI-IgE complex.. Eur Biophys J 25(5-6):471-6 PMID: 9188170
- 8. Malbec O et al.. 1998. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation.. J Immunol 160(4):1647-58 PMID: 9469421
